Prior authorization for weight loss medication is the insurance review step that decides whether your plan will cover a branded GLP-1 like Wegovy or Zepbound, and it is usually the difference between paying a copay and paying full retail. It is paperwork, not a verdict on whether you need treatment. This guide explains what prior authorization is, what your clinician submits, why requests get denied, and how to appeal.
A prior authorization is a request your clinician sends to your insurer documenting that a specific medication is medically appropriate for you. For GLP-1 receptor agonists prescribed for weight management, plans almost always require it before they pay, and the quality of the submitted documentation drives the outcome more than anything else.
- Prior authorization is a coverage rule your insurer applies, not a clinical judgment on whether you need treatment.
- Approval odds depend on the documentation submitted: diagnosis, BMI trend, related conditions, and prior weight-management attempts.
- Coverage criteria vary widely by plan, so identical prescriptions can mean very different out-of-pocket costs.
- Most first-round denials are administrative and fixable through appeal, peer-to-peer review, or switching to a covered alternative.
- If a plan excludes weight-loss drugs entirely, manufacturer savings programs or the branded cash price are the realistic paths.
- At GoodLife Health, prior authorization and appeals are included in the $399 a month medical weight loss tier, with no margin taken on the medication.
It is paperwork, not a verdict on whether you need treatment.
What is prior authorization for weight loss medication
Prior authorization is a coverage rule, not a clinical one. Your clinician can write a valid prescription for semaglutide or tirzepatide, but the pharmacy cannot bill your insurer for it until the plan approves the request. The insurer checks the prescription against its own coverage criteria: your diagnosis, your body mass index, documented prior attempts at weight management, and sometimes related conditions such as prediabetes, hypertension, or sleep apnea.
The criteria vary by plan, which is why two people on the same medication can have completely different out-of-pocket costs. One plan may cover Wegovy at a BMI of 30, another may require a BMI of 27 with a weight-related condition, and a third may exclude weight-loss drugs entirely while still covering the same molecule for type 2 diabetes.
How coverage criteria can differ by plan
Same medication, different rules
| Plan example | Coverage rule |
|---|---|
| Plan A | Covers Wegovy at a BMI of 30 |
| Plan B | Requires a BMI of 27 with a weight-related condition |
| Plan C | Excludes weight-loss drugs entirely, while still covering the same molecule for type 2 diabetes |
What your clinician submits
A strong prior authorization request reads like a clinical case, not a form. At GoodLife Health, your clinician orders and reads the labs and assembles the documentation the plan is looking for:
- Your diagnosis and current body mass index, with the trend over time.
- Weight-related conditions on the chart, such as prediabetes with a documented A1c, dyslipidemia, hypertension, or obstructive sleep apnea.
- A record of prior weight-management efforts, since many plans require evidence that lifestyle change alone was tried.
- The specific drug, dose, and titration plan, matched to the indication the plan covers.
The point of the package is to answer the insurer's questions before they are asked. A request that names the diagnosis, attaches the lab values, and matches the covered indication is approved far more often than a bare prescription.
Why requests get denied, and how to appeal
Most first-round denials are administrative, not clinical. The common reasons are a missing lab value, a BMI that was not documented in the chart, a request for an indication the plan does not cover, or a step-therapy rule that requires trying a different drug first. None of these mean you are ineligible. They mean the file was incomplete or pointed at the wrong coverage pathway.
If your request is denied, your clinician can file an appeal with the missing documentation, request a peer-to-peer review where the prescriber speaks directly with the plan's medical reviewer, or switch the request to a covered alternative. The Food and Drug Administration's overview of semaglutide products is a useful reference for understanding which branded products are approved for which use, because matching the indication to the product is often what unblocks a denial.
If your plan will not cover it at all
Some plans exclude weight-loss medication entirely. When that happens, prior authorization is not the path, and the realistic options are manufacturer savings programs, which can substantially lower the monthly price for eligible patients, or paying the cash price for the branded product. This is also the moment when some patients consider compounded versions to cut cost. The regulatory ground there has shifted, and you can read what changed with compounded GLP-1 before making that decision. The branded, FDA-approved medication is the standard of care now that the shortage has resolved.
How GoodLife handles the paperwork
At GoodLife Health, medical weight loss sits in the $399 a month tier, and the prior authorization work is part of the care, not an add-on. The clinician documents the diagnosis, orders and reviews the labs, submits the request, and handles appeals and peer-to-peer reviews when needed. The medication itself is a separate cost you pay to the pharmacy. GoodLife takes no margin on the prescription, which is the structural point: the clinician's only incentive is to get you covered and treated, not to sell you a drug. You can see how the tiers work on the pricing page.
That separation matters more than it sounds. When the company writing the prescription also profits from selling it, the documentation tends to favor whatever is in stock. When the clinician earns nothing on the medication, the prior authorization is written to get you the right drug at the lowest cost to you, even when that means a covered alternative instead of the first choice.
What to do while you wait for a decision
A prior authorization is not the only thing happening once you decide to start treatment, and the waiting period is not dead time. A good clinician uses it. Your baseline labs, an A1c, a lipid panel, kidney and liver function, and a metabolic panel, are drawn and reviewed so that the day coverage clears, the titration can begin safely rather than starting from scratch. The nutrition and resistance-training plan that protects muscle is set up in parallel, because the medication is one input and not the whole protocol.
If your plan uses step therapy, meaning it requires you to try a preferred drug before the one requested, that requirement is documented and addressed up front rather than discovered at the pharmacy counter. If your plan has an exclusion, the savings-program and cash pathways are priced before you commit, so there are no surprises. The aim is that the approval, when it comes, lands on a plan that is already built, not on an empty chart.
Common mistakes that cause delays
Most avoidable delays trace back to a handful of errors: submitting a prescription without the supporting diagnosis and BMI in the chart, requesting an indication the plan does not cover, missing a required lab value, or sending the request to the wrong benefit, the pharmacy benefit versus the medical benefit. Each of these is fixable, and each is faster to prevent than to appeal. A clinician who builds prior authorizations regularly knows the common failure points for the major plans and writes the request to clear them on the first pass, which is the practical difference between a week and a month.
Frequently Asked Questions
How long does prior authorization for weight loss medication take?
Most plans respond within a few business days once a complete request is submitted, though some take up to two weeks. A request with the diagnosis, BMI, and supporting labs already attached moves faster than one that triggers a request for more information.
What information does insurance require to approve a GLP-1?
Plans typically require a documented diagnosis, current body mass index, any weight-related conditions such as prediabetes or hypertension with supporting labs, and often a record of prior weight-management efforts. The exact criteria are set by each plan.
Can I appeal a denied prior authorization?
Yes. Denials are frequently administrative and can be appealed with the missing documentation, through a peer-to-peer review where your prescriber speaks with the plan's reviewer, or by switching to a covered alternative medication.
Does GoodLife Health charge extra to handle prior authorization?
No. Prior authorization, lab review, and appeals are part of the clinical membership. The medication is a separate cost paid directly to the pharmacy, and GoodLife takes no margin on it.
What if my insurance does not cover weight loss medication at all?
When a plan excludes weight-loss drugs, the realistic paths are manufacturer savings programs or paying the branded cash price. Your clinician can confirm eligibility and document the most affordable covered route for your situation.
Related Reading
- Best Medical Weight Loss Programs: The Clinically Honest Guide for 2026
- Compounded vs Branded GLP-1: What Changed in 2025
- GLP-1 for Prediabetes and Insulin Resistance
- GLP-1 Side Effects: What to Expect and How to Manage Them
- Medical Weight Loss Without Surgery: Options That Work
References
- U.S. Food and Drug Administration. Medications Containing Semaglutide: Safety Information.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med, 2021.
This article is informational only and is not medical advice. GoodLife Health is a direct primary care telehealth membership, not a pharmacy, compounder, or supplement seller, and it does not manufacture, compound, dispense, ship, or take title to any medication. Individual results vary. Consult a licensed clinician.